YMRC
DPLO

Yorktown Management & Research Company’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Yorktown Management & Research Company’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,000
Closed -$201K – 470
2015
Q3 		$201K Hold
7,000
– – 0.03% 425
2015
Q2 		$313K Hold
7,000
– – 0.05% 224
2015
Q1 		$242K Buy
+7,000
New +$190K 0.04% 359

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Yorktown Management & Research Company's DPLO Position: Q4 2015 in Review

Yorktown Management & Research Company sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2015, closing a stake of 7,000 shares — an estimated $201K sold.

Yorktown Management & Research Company first reported a position in DPLO in Q1 2015 and held it in 3 quarters. The position peaked at $313K in Q2 2015. 151 funds tracked by Wall St. Rank hold DPLO as of Q4 2015.

  • Yorktown Management & Research Company reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2015 after selling out during the quarter.
  • Yorktown Management & Research Company sold 7,000 DIPLOMAT PHARMACY, INC. shares in Q4 2015, an estimated $201K.
  • Yorktown Management & Research Company first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 3 quarters.
  • Yorktown Management & Research Company's DIPLOMAT PHARMACY, INC. position peaked at $313K in Q2 2015.
  • 151 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2015.

Based on Yorktown Management & Research Company's 13F filing for Q4 2015, filed 27 Jan 2016.